S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
Log in

Ocugen News Headlines (NASDAQ:OCGN)

$2.15
+0.33 (+18.13 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$1.75
Now: $2.15
$2.19
50-Day Range N/A
52-Week Range
$1.22
Now: $2.15
$50.40
Volume3.19 million shs
Average Volume435,435 shs
Market Capitalization$3.40 million
P/E RatioN/A
Dividend YieldN/A
Beta3

Headlines

Ocugen (NASDAQ OCGN) News Headlines

Source:
DateHeadline
32 Healthcare Stocks Moving In Fridays Pre-Market Session32 Healthcare Stocks Moving In Friday's Pre-Market Session
www.msn.com - October 18 at 2:12 PM
Ocugen (OCGN) and Its Competitors Financial AnalysisOcugen (OCGN) and Its Competitors Financial Analysis
www.americanbankingnews.com - October 14 at 1:31 PM
Ocugen (OCGN) versus Its Peers Head to Head ReviewOcugen (OCGN) versus Its Peers Head to Head Review
www.americanbankingnews.com - October 13 at 7:31 AM
Ocugen (OCGN) & Its Peers Head-To-Head AnalysisOcugen (OCGN) & Its Peers Head-To-Head Analysis
www.americanbankingnews.com - October 12 at 6:21 PM
Head-To-Head Survey: Ocugen (OCGN) and Its PeersHead-To-Head Survey: Ocugen (OCGN) and Its Peers
www.americanbankingnews.com - October 11 at 11:30 PM
Head-To-Head Survey: Ocugen (OCGN) vs. The CompetitionHead-To-Head Survey: Ocugen (OCGN) vs. The Competition
www.americanbankingnews.com - October 9 at 11:36 PM
Critical Review: Ocugen (OCGN) & Its RivalsCritical Review: Ocugen (OCGN) & Its Rivals
www.americanbankingnews.com - October 9 at 7:27 PM
Head to Head Analysis: Ocugen (OCGN) versus Its CompetitorsHead to Head Analysis: Ocugen (OCGN) versus Its Competitors
www.americanbankingnews.com - October 9 at 11:54 AM
Insider Buying: Ocugen (NASDAQ:OCGN) Director Acquires 31,078 Shares of StockInsider Buying: Ocugen (NASDAQ:OCGN) Director Acquires 31,078 Shares of Stock
www.americanbankingnews.com - October 9 at 11:20 AM
Ocugen Announces Share Repurchase ProgramOcugen Announces Share Repurchase Program
finance.yahoo.com - October 9 at 10:13 AM
Contrasting Ocugen (OCGN) & Its PeersContrasting Ocugen (OCGN) & Its Peers
www.americanbankingnews.com - October 8 at 9:05 PM
Ocugen Announces Completion of its Merger with Histogenics to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and BiotherapeuticsOcugen Announces Completion of its Merger with Histogenics to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics
finance.yahoo.com - October 8 at 4:37 PM
Ocugen and CanSinoBIO Enter Strategic Partnership for Gene Therapy Co-Development and ManufacturingOcugen and CanSinoBIO Enter Strategic Partnership for Gene Therapy Co-Development and Manufacturing
finance.yahoo.com - October 8 at 4:37 PM
Ocugen to Present at Three Upcoming ConferencesOcugen to Present at Three Upcoming Conferences
finance.yahoo.com - October 8 at 4:37 PM
Ocugen Appoints Sanjay S. Subramanian, MBA, as Chief Financial OfficerOcugen Appoints Sanjay S. Subramanian, MBA, as Chief Financial Officer
finance.yahoo.com - October 8 at 4:37 PM
Ocugen Announces Amendment to Asset Purchase AgreementOcugen Announces Amendment to Asset Purchase Agreement
finance.yahoo.com - October 8 at 4:37 PM
Zacks: Ocugen (NASDAQ:OCGN) Given Consensus Rating of "Hold" by BrokeragesZacks: Ocugen (NASDAQ:OCGN) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - October 7 at 10:18 PM
Ocugen (NASDAQ:OCGN) Director Acquires $1,999,985.00 in StockOcugen (NASDAQ:OCGN) Director Acquires $1,999,985.00 in Stock
www.americanbankingnews.com - October 7 at 8:49 PM
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: Stocks at 52 Week High

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel